Macrolide pharmacodynamics in serum and epithelial lining for Streptococcus pneumoniae

被引：0
|
作者：
Frei, CR
Burgess, D
机构：
[1] Univ Texas, Austin, TX 78712 USA
[2] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78285 USA
来源：
PHARMACOTHERAPY | 2004年 / 24卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
126
引用
收藏
页码：1440 / 1441
页数：2
相关论文
共 50 条
  • [1] Pharmacodynamics of moxifloxacin and levofloxacin at simulated epithelial lining fluid drug concentrations against Streptococcus pneumoniae
    Florea, NR
    Tessier, PR
    Zhang, CL
    Nightingale, CH
    Nicolau, DP
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) : 1215 - 1221
  • [2] Pharmacodynamic of intravenous azithromycin at simulated serum and epithelial lining fluid drug concentrations against macrolide-resistant and -susceptible Streptococcus pneumoniae
    Echeverría, O
    Alou, L
    Sevillano, D
    Cafini, F
    López-casla, MT
    Unzueta, I
    Prieto, J
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S110 - S110
  • [3] Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations
    Zhanel, GG
    Johanson, C
    Hisanaga, T
    Mendoza, C
    Laing, N
    Noreddin, A
    Wierzbowski, A
    Hoban, DJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (06) : 1072 - 1077
  • [4] Macrolide Resistance in Streptococcus pneumoniae
    Schroeder, Max R.
    Stephens, David S.
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2016, 6
  • [5] Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations
    Zhanel, GG
    DeCorby, M
    Noreddin, A
    Mendoza, C
    Cumming, A
    Nichol, K
    Wierzbowski, A
    Hoban, DJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) : 83 - 88
  • [6] Macrolide and ketolide resistance with Streptococcus pneumoniae
    Doern, Gary V.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2006, 90 (06) : 1109 - +
  • [7] Significance of macrolide resistance in Streptococcus pneumoniae
    Nuermberger, EL
    Bishai, WR
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (03) : 524 - 525
  • [8] Macrolide resistance in Belgian Streptococcus pneumoniae
    Lagrou, K
    Peetermans, WE
    Verhaegen, J
    Van Lierde, S
    Verbist, L
    Van Eldere, J
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (01) : 119 - 121
  • [9] Detection of macrolide resistance in Streptococcus pneumoniae
    Kimura, T
    Horii, T
    Morita, M
    Muramatsu, H
    Kanno, T
    Maekawa, M
    [J]. CHEMOTHERAPY, 2003, 49 (1-2) : 56 - 61
  • [10] Pharmacodynamic modeling of telithromycin and azithromycin vs. genotypically characterized (mefA and ermB) macrolide resistant strains of Streptococcus pneumoniae simulating free serum and free epithelial lining fluid concentrations.
    Noreddin, AM
    Hoban, D
    Zhanel, GG
    [J]. PHARMACOTHERAPY, 2005, 25 (03): : 474 - 474
12345